[PDF] Top 20 Using Stem Cells to Model Diseases of the Outer Retina
Has 10000 "Using Stem Cells to Model Diseases of the Outer Retina" found on our website. Below are the top 20 most common "Using Stem Cells to Model Diseases of the Outer Retina".
Using Stem Cells to Model Diseases of the Outer Retina
... retinal cells are an ideal in vitro model for disease ...of diseases, including, RP, but also deliver a means of identifying possible therapeutic strategies ...broblast cells from fi ve RP ... See full document
9
Stem cells: a potential treatment option for kidney diseases
... − cells when injected into mice with adriamycin-induced nephropathy glomerular, which are engrafted into the glomerular structures and tubular structures, accounted for ...tubular cells in ...− cells ... See full document
20
Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases
... the model of endotoxin-induced ALI in mice lead to the least infiltration of inflammatory cells, no apoptosis, and maintained lung architecture ...ARDS model in rabbit, the absence of calcification ... See full document
11
Promoting vascular repair in the retina: can stem/progenitor cells help?
... vascular retina, and this knowledge will facilitate the translation of basic studies into clinical ...vascular diseases, providing a framework for their study in animal ... See full document
10
Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond
... the cells to self-organize and proceed along a developmental trajectory not unlike that which occurs in vivo ...to model human diseases, particularly those affecting developmental ... See full document
6
The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases
... colleagues using the four Yamanaka factors, which were then excised by Cre-mediated recombination in 2009 ...animal model for the fi rst time [2]. Using a scalable process for the production of ... See full document
6
Mesenchymal stem cells in osteoarticular diseases: an update
... infarction model, SDF-1 expression was increased only in the early phase post infarct stimulating the recruitment of MSCs to injured heart as well as enhanced angiogenesis and improved cardiac function ...of ... See full document
10
Mesenchymal stem cells in arthritic diseases
... T cells stimulate monocytes, macrophages, and FLSs to produce inflammatory mediators, including IL-1, TNF- α , IFN- γ , and IL-6, and secrete MMPs, leading to the systemic inflammation that eventually results in ... See full document
12
Induced pluripotent stem cells in the study of neurological diseases
... study using iPS cells to model a disease, Ebert and colleagues generated iPS cells from a SMA patient and used them to derive motor neurons ...control cells – suggesting that SMA motor ... See full document
9
Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis
... AFS cells are primary cells of a very early stage of human ...AFS cells, unlike ES and iPS cells, do not induce tumor formation in severe combined immunodeficient mice ...AFS cells, ... See full document
8
Clinical potentials of human pluripotent stem cells in lung diseases
... Bleomycin (BLM)-induced alveolar injury is well charac- terized in mice [46,47], and has been used as a model to test therapeutic potential of hES-ATIICs [45]. When transplanted into SCID mice on day 1 or 2 after ... See full document
8
Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases
... into cells that show contractile ...MI model, which resulted in noticeable improvements in cardiac function and the prevention of myocardial remodeling via secretion of the proangiogenic factors VEGF, HGF, ... See full document
9
Human pluripotent stem cells: an emerging model in developmental biology
... of diseases, including monogenic diseases such as spinal muscular atrophy (SMA) and complex diseases such as Parkinson’s disease (Wu and Hochedlinger, ...of using iPSCs to model a ... See full document
13
A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases
... “magnetic” cells, and thus markedly enhanced vascular density ...of stem cells was used to increase the implanted ADSC retention in the infarcted ...ischemic diseases via increasing cell ... See full document
8
Vascular endothelial growth factor A165b ameliorates outer retinal barrier and vascular dysfunction in the diabetic retina
... measured using electric cell-substrate impedance sensing (ECIS, Applied Biophysics, NY, ...U.S.A.) using a 1600R ECIS model. Cells were plated on eight-well plates (8W10E + plates, Applied ... See full document
19
Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells
... photoreceptor outer segments and subsequent photoreceptor death in the macula, resulting in central vision loss (Sparrow et ...the retina, leading to wet AMD and a rapid, devastating loss of central vision ... See full document
14
Tight junctions of the outer blood retina barrier
... retinal diseases that feature degeneration of rod and cone PRs and characteristic retinal deposits ...rare model of X-linked RP) demonstrate a decrease in the intensity of ZO-1 staining ... See full document
12
Stem cells for the treatment of neurodegenerative diseases
... (GM-CSF), stem cell factor, vascular endo- thelial growth factor (VEGF), and stromal cell-derived factor-1-alpha (SDF-1-alpha) in ischemic stroke ...of stem cells to augment growth factor in AD in ... See full document
7
Molecular and Biochemical Studies on Stem Cells in Relation to certain Hepatic Diseases
... Animal model of liver fibrosis and cirrhosis was induced by subcutaneous injection of CCl4 at a dose of ...mesenchymal stem cells (BM-MSCs) and fifty healthy male albino rats weighting 180-220g were ... See full document
8
To unite or divide: mitochondrial dynamics in the murine outer retina that preceded age related photoreceptor loss
... mice using immunostaining and Western blot. With immunostaining we quantify differences between young and old where these appear to be obvious. Figure 1A shows that the intensity of Fis1 labelling is significantly ... See full document
12
Related subjects